These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 438966)

  • 1. Quinidine and dihydroquinidine interactions in human plasma.
    Ueda CT; Makoid MC
    J Pharm Sci; 1979 Apr; 68(4):448-50. PubMed ID: 438966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dihydroquinidine on in vitro and in vivo quinidine disposition.
    Ueda CT
    Biochem Pharmacol; 1980 Mar; 29(5):737-40. PubMed ID: 20227949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointes.
    Thompson KA; Murray JJ; Blair IA; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1988 Jun; 43(6):636-42. PubMed ID: 3378385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma protein binding of 3-(S) or 3-(R) hydroxylated derivatives of quinidine and dihydroquinidine].
    Leroyer R; Varoquaux O; Guillebastres R; Jarreau C; Normand JP; Jaillon P; Advenier C; Pays M
    Therapie; 1986; 41(3):159-62. PubMed ID: 3750253
    [No Abstract]   [Full Text] [Related]  

  • 5. Disposition kinetics of dihydroquinidine following quinidine administration.
    Ueda CT; Williamson BJ; Dzindzio BS
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of quinidine and dihydroquinidine in humans.
    Hailey DM; Lea AR; Coles DM; Heaume PE; Smith WJ
    Eur J Clin Pharmacol; 1981; 21(3):195-9. PubMed ID: 7318878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroquinidine contamination of quinidine raw materials and dosage forms: rapid estimation by high-performance liquid chromatography.
    Narang PK; Crouthamel WG
    J Pharm Sci; 1979 Jul; 68(7):917-9. PubMed ID: 458617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting quinidine protein binding in humans.
    Edwards DJ; Axelson JE; Slaughter RL; Elvin AT; Lalka D
    J Pharm Sci; 1984 Sep; 73(9):1264-7. PubMed ID: 6491948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration.
    Chimienti M; Regazzi MB; La Rovere MT; Salerno JA; Previtali M; Montericcio V; Rondanelli R; Montemartini C
    Cardiovasc Drugs Ther; 1988 Dec; 2(5):679-86. PubMed ID: 2484920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid high-pressure liquid chromatographic determination of quinidine and dihydroquinidine in plasma samples.
    Kates RE; McKennon DW; Comstock TJ
    J Pharm Sci; 1978 Feb; 67(2):269-70. PubMed ID: 621655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of quinidine, dihydroquinidine, (3S)-3-hydroxyquinidine and quinidine N-oxide in plasma and urine by high-performance liquid chromatography.
    Nielsen F; Nielsen KK; Brøsen K
    J Chromatogr B Biomed Appl; 1994 Oct; 660(1):103-10. PubMed ID: 7858702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro electrophysiology of quinidine, its major metabolites and dihydroquinidine.
    Thompson KA; Blair IA; Woosley RL; Roden DM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):84-90. PubMed ID: 3572799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of yeast-expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolites.
    Ching MS; Blake CL; Ghabrial H; Ellis SW; Lennard MS; Tucker GT; Smallwood RA
    Biochem Pharmacol; 1995 Sep; 50(6):833-7. PubMed ID: 7575645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration.
    Ueda CT; Dzindzio BS
    Eur J Clin Pharmacol; 1979 Sep; 16(2):101-5. PubMed ID: 499305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific thin-layer chromatographic method for the determination of quinidine in biological fluids.
    Wesley-Hadzija B; Mattocks AM
    J Chromatogr; 1977 Dec; 144(2):223-30. PubMed ID: 925112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma binding and decreased blood cell binding of quinidine in blood from anuric rats.
    Fremstad D
    Acta Pharmacol Toxicol (Copenh); 1977 Aug; 41(2):148-60. PubMed ID: 579054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of quinidine analogs using ion-pairing HPLC.
    Al-Kaysi HN; Small LD; Murray WJ; Haddadin M
    J Chromatogr Sci; 1984 Feb; 22(2):80-3. PubMed ID: 6699121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing serum protein binding of lidocaine in humans.
    McNamara PJ; Slaughter RL; Pieper JA; Wyman MG; Lalka D
    Anesth Analg; 1981 Jun; 60(6):395-400. PubMed ID: 6165258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.